Navigation Links
New Stroke Treatment Enables People Who Have Been Confined to a Wheelchair to Walk Again Utilizing Stretching Therapy Together With Perispinal Etanercept Injections
Date:10/23/2013

(PRWEB) October 23, 2013

Phillip Koss, owner of http://www.strechforlife.com/ is quick to point out that this process is no panacea. A severely disabled individual will need weeks of daily treatments, as much as two hours twice daily. Commitment and dedication is required of both the patient and practitioner. Each session is individually tailored to meet the specific needs of the person at each stage in the process. Since 2009, Stretch for Life has been enabling persons with stroke and traumatic brain injury (TBI) to regain feeling and function. The process involves full body stretching, massage, acupressure, strength training coupled with mental focus, breathing and visualization to eliminate spasticity and restore feeling and muscle function. Once the habitually tight muscles have been coaxed into relaxing, the relaxation is permanent. Persons who have been in chronic pain report the pain is alleviated.The process begins as a series of treatments to relax the tight muscles and continues as a relearning to use the atrophied muscles. Lastly, the procedure involves exercises to restore strength and coordination.

"By pretreating a client with perispinally administered etanercept (Enbrel), we vastly speed up the entire process and obtain results that would not be possible without the Enbrel," stated Phillip Koss a ATQDA certified motor skills specialist. For example, an individual with stroke who is completely unable to walk and confined to a wheelchair could, after a series of daily treatments over several months, walk with a walker or even crutches. When such an individual is pretreated with perispinally administered Enbrel, the treatment is shortened from several months to a few weeks and the individual may be able to walk entirely unaided. Some of these people have been so pleased with their outcomes they have contacted various news media. A collection of these reports appeared in: http://www.prweb.com/releases/2013/7/prweb10903745.htm

There is a growing body of evidence linking chronic inflammatory events in the brain with many of the impairments persons with stroke and TBI experience. Enbrel is a drug approved to treat the acute inflammatory processes involved in certain forms of arthritis and psoriasis. Newly published research* finds: "The stroke and TBI induced cerebral ischemia, neurological motor deficits, and increased numbers of microglia-TNF-alpha double positive cells and increased TNF-alpha levels in the injured brain were all significantly attenuated by etanercept therapy." Rolando Hernandez M.D., a neurosurgeon at Neurological Wellness Center, states, "This research elucidates the neurological mechanisms that enable improvements in walking ability, arm movement, speech, mood, and reductions in spasticity that we see in the patients we have treated with perispinally administered Enbrel brand etanercept. The treatment protocol utilized by Neurological Wellness Center was pioneered by http://reversealzheimersnow.com/ Edward Tobinick M.D. in 2006 and described in Expert Reviews of Neurotherapeutics.

"Stroke and TBI result in a self-perpetuating cycle of inflammation in the brain. This excess inflammation persists for years or even decades after the injury. This excess inflammation contributes to a portion of the many impairments our patients experience. Perispinally administered Enbrel reduces this inflammation in the brain, facilitating a recovery of function," stated Rolando Hernandez, M.D.

"These results represent a sea change in the therapeutic possibilities for stroke and TBI patients. Our team observed firsthand, rapid clinical improvement in stroke patients following this brief office treatment," said Dr. Steve Ralph, professor at Griffith University School of Medical Science in Austrailia. Dr. Ralph visited Neurological Wellness Center in Managua, Nicaragua in 2012 where he learned to perform perispinal injections," said Dr. Augusto Ramirez, M.D. of Neurological Wellness Center. Neurological Wellness Center physicians began teaching perispinal injection technique for the drug Enbrel in 2010. Since then physicians, nurses and caregivers from every continent have visited the center. "We have amassed a trove of anecdotal reports confirming the efficacy of perispinally injected Enbrel for the treatment of stroke and TBI," said Dr. Ramirez.

"Perispinal Enbrel as a TBI treatment has many attributes. (1) The therapeutic window is wide. A person whose injury occurred a decade ago or even longer may still benefit. (2) The treatment is short term, yet the benefits are long-lasting. (3) The dosage of Enbrel needed to achieve these results is quite low compared to the FDA recommendations for moderate plaque psoriasis. The FDA protocol for moderate plaque psoriasis calls for 24 injections totaling 1200 mg of Enbrel over a three-month period, followed by weekly injections for life. Whereas a person with moderate to severe stroke or TBI would need a maximum of 4 injections totaling 100 mg of Enbrel in this period and would be unlikely to need even a single booster injection. (4) The recovery - improvements can begin to occur in minutes and can build with subsequent injections over a four- to eight-week period," stated Dr. Hernandez.

Neurological Wellness Center offers a complete two-hour course on stroke treatment and traumatic brain injury treatment covering all aspects of perispinal injection technique at their Neurological Wellness Center in Managua, Nicaragua.

For many, flying to the Neurological Wellness Center in Nicaragua to receive this personalized training is an enormous expense and inconvenience. To overcome this problem, Neurological Wellness Center, under the direction of Augusto Ramirez, M.D., created Perispinal Enbrel Step-By-Step Instructional Video and accompanying e-book. This 24-minute video and 37-page e-book are now available online at http://www.neurological-recovery-guide.com.

Augusto Ramirez, M.D., Director of Neurological Wellness Center, a private medical group in Managua Nicaragua, authorized this press release.

Neurological Wellness Center’s perispinal Enbrel is profoundly effective as a stroke treatment and TBI treatment.The drug Enbrel is available now. Enbrel received FDA approval in 1998. Its safety profile is well understood. Enbrel is a highly advertised, commonly prescribed drug manufactured by Immunex for Amgen/Pfizer. Over 400,000 Americans self-inject Enbrel each week, mostly as a treatment for rheumatoid arthritis. Enbrel is a powerful anti-inflammatory agent. Dr. Augusto believes many of the impairments people with TBI or stroke experience are due to a self-perpetuating cascade of inflammation that was initiated by the brain injury. This perispinal injection allows Enbrel to enter the brain by lymph drainage assisted by gravity. "Fortunately for the millions of people now afflicted with stroke and TBI, a video is now available online detailing in step-by-step fashion how to administer a perispinal injection of Enbrel," said Dr. Rolando Hernandez M.D.

To enroll in a hands-on instructional course on perispinal injections, visit http://www.reversealzheimersnow.com.

To purchase an instructional video and e-book on administering perispinal injections, visit http://www.neurological-recovery-guide.com.

To schedule an appointment with strechforlife at their office in Waco, Texas, visit: http://www.strechforlife.com/ or call: 254-717-0641

  • .ingentaconnect.com/content/ben/ctmc/2009/00000009/00000014/art00002

Read the full story at http://www.prweb.com/releases/2013/10/prweb11175894.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Flu shot halves risk of heart attack or stroke in people with history of heart attack, study finds
2. Flu shot halves risk of heart attack or stroke in people with history of heart attack, study finds
3. Excessive alcohol consumption increases the progression of atherosclerosis and the risk of stroke
4. Tests in mice identify compound that may keep survivors of brain aneurysms from succumbing to stroke
5. Telestroke service increases rates of clot-buster treatment for stroke, reports Neurosurgery
6. Birmingham Personal Injury Lawyers of Belt Law Firm, P.C., Discuss New Studies on Link between Strokes, TBI
7. YogaFit and The American Heart Association Collaborate to Raise Heart and Stroke Health Awareness in Southern California
8. Acute Ischemic Stroke Market (AIS): Analyzed and 2022 Forecasts in New Research Report at RnRMarketResearch.com
9. DrugNews: Pradaxa Study Reveals Stroke, Bleeding and Heart Attack Risks In Some Patients
10. Anti-inflammatory and anti-thrombogenic effects of atorvastatin in acute ischemic stroke
11. MRI may predict heart attack and stroke risk in people with diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... California Senate ... medical payments per workers’ compensation claim in 2013 and 2014, according to CompScope™ ... Research Institute (WCRI) . , According to the study, medical payments per claim in ...
(Date:12/8/2016)... ... December 08, 2016 , ... The Dianne Michael ... headquartered in Hamilton County, is embarking on a charity drive with the aim ... new homes for orphaned or neglected senior dogs in the Cincinnati region, and ...
(Date:12/8/2016)... Fort Payne, AL (PRWEB) , ... December 08, ... ... enterprise offering insurance and financial consulting services to residential and commercial clients in ... raise awareness and support for Nobis Works. , Since 1977, Nobis Works has ...
(Date:12/7/2016)... Wisconsin (PRWEB) , ... December 07, 2016 , ... Kenall ... extraordinary new MedMaster™ MPCNGX . The MPCNGX is a multi-function, sealed, LED luminaire ... right amount of light where and when it’s needed. , A 2’ ...
(Date:12/7/2016)... ... December 07, 2016 , ... ... (“Presence”) for a purchase price of approximately $17.4 million (net of the ... revenue is approximately $13.2 million. Headquartered in Barcelona, Spain, Presence is a ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... Dec. 8, 2016  A new study by a ... use of opioid therapy to treat chronic pain is ... of more harmful consequences, including death. Palliative ... Zankhana Mehta , M.D., authored the study which ... opioid therapy. The study was published in the December ...
(Date:12/8/2016)... 2016  EIP Pharma, LLC ( www.eippharma.com ) ... neflamapimod (previously code named VX-745), with the results ... that demonstrated significant Alzheimer,s disease relevant pharmacological activity.  ... Study 303 (6-week treatment) are the subject of ... (CTAD) scientific conference in San Diego, ...
(Date:12/8/2016)... Mederi Therapeutics Inc . hat die behördliche Zulassung durch die CFDA sowie ... – in China angekündigt. ... ... Live Stretta procedure performed and broadcast during the Chinese Congress ... Union Hospital ...
Breaking Medicine Technology: